Synakis Corp.
Toronto, CA · 2 known investors
Find your way into Synakis Corp.
256 people in our graph share verified history with the Synakis Corp. team — schools, employers, funds. One of them is your warm intro.
Hemant Tanejaunlockedknows Thierry Nivaggioli · together at Massachusetts Institute of Technology (overlapped)
×9knows the team · via Massachusetts Institute of Technology
knows the team · via University of Toronto
knows the team · via Allergan
Synakis develops ocular biomaterials, including its lead candidate SNK-125, through pre-clinical research and a pipeline of eye-related products. The company operates in the ophthalmic biomaterial and biotech space.
Founders & leadership
TN
Thierry NivaggioliinCEOThierry Nivaggioli is a biotech executive with over 25 years in ophthalmology, drug delivery, and biomaterials, and currently serves as CEO of Synakis, which develops ocular biomaterial platforms for retinal surgery and long-acting drug delivery systems targeting glaucoma and retinal diseases.
Investors · 2
In the news
Frequently asked questions
- What does Synakis Corp. do?
- Synakis develops ocular biomaterials, including its lead candidate SNK-125, through pre-clinical research and a pipeline of eye-related products. The company operates in the ophthalmic biomaterial and biotech space.
- Who are Synakis Corp.'s investors?
- Synakis Corp.'s investors include Ontario Centre of Innovation, Ontario Centre of Innovation programs.
- Where is Synakis Corp. headquartered?
- Synakis Corp. is headquartered in Toronto, CA.